4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-16-141654
Options or other derivatives
- Chief Medical Officer acquired 27,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Shukla Sanjay Chief Medical Officer | 2016-09-13 | Grant or award · Employee Stock Option (right to buy) | +27,500 | 27,500 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…